Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB prevention news


From To
TB Treatment May Leave Some Patients Contagious

The World Health Organization’s dosage guidelines for two leading tuberculosis medications may be far too low for patients with H.I.V., allowing them to remain contagious for longer than necessary, a new study has found.

09 April 2018
New York Times
Latent TB high in India's healthcare workers

While India continues to have the highest burden of tuberculosis in the world, about 23 per cent of the 8.7 million global incidences, a study reports nearly half of its healthcare workers taking care of TB patients also suffer from latent tuberculosis.

17 October 2016
TB drugs may be disrupted by botanical supplement, MU researchers find

MU researchers, working with scientists in Africa, discovered that a widely used African botanical supplement called Sutherlandia — traditionally taken to prevent or treat symptoms of infections — may actually disrupt the effectiveness of a common anti-tuberculosis drug, isoniazid.

11 October 2016
Kansas City Star
Zimbabwe study sees TB go down as HIV treatment coverage goes up

As the numbers of people accessing HIV treatment went up in Zimbabwe, the numbers of reported tuberculosis cases were cut nearly in half.

06 October 2016
Science Speaks
Scientists explain why Russian tuberculosis is the most infectious

Scientists conducted a large-scale analysis of the proteins and genomes of mycobacterium tuberculosis strains that are common in Russia and countries of the former Soviet Union and found features that provide a possible explanation for their epidemiological success.

19 August 2016
Eurekalert Medicine & Health
UNITAID launches global initiative to prevent tuberculosis

UNITAID is calling for innovative proposals to make new, shorter preventive treatment regimens more easily available to those who could benefit most. The proposals that show most promise will be recommended for funding.

25 May 2016
Leave no one behind: Stop TB Partnership launches seven key population briefs

The Stop TB Partnership today launched a series of briefs on TB key populations recognizing that reaching everyone with services, diagnostics, treatment and care is essential to ending the TB epidemic.

17 May 2016
Stop TB Partnership
Proactively treating HIV patients at risk for tuberculosis with multidrug TB therapy doesn’t save more lives

In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in people with advanced HIV/AIDS infections. Those with HIV and AIDS are highly susceptible to TB.

21 March 2016
Johns Hopkins Medicine
Screen High-Risk Adults for Tuberculosis, Experts Say

Adults at greater risk for latent tuberculosis infection should be screened for the condition, the U.S. Preventive Services Task Force recommends.

09 March 2016
U.S. News & World Report
Sanofi: FDA Approves Priftin Tablets To Treat Latent Tuberculosis Infection

French drug maker Sanofi announced Tuesday that Priftin (rifapentine) tablets for the treatment of latent tuberculosis infection has received approval from the U.S. Food and Drug Administration.

02 December 2014
RTT News
← First12345...7Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.